👀 Copy Legendary Investors' Portfolios in One ClickCopy For Free

Cathie Wood's ARK trims Markforged stock, continues pattern

Published 12/10/2024, 08:02 PM
MKL
-
ARKQ
-

Cathie Wood's ARK ETF disclosed their daily trades for Tuesday, December 10th, 2024, revealing a continuation of its recent selling pattern with a focus on Markforged Holding Corp (NYSE:MKFG). The innovation-focused investment firm, known for its concentration on disruptive technologies, offloaded a modest total of 50 shares of Markforged through its ARKQ ETF, valued at $215. This move follows a series of sales in the previous week involving the same company, suggesting a strategic reduction in ARK's position.

Looking back at ARK's trading activity since last week, there is a notable trend in the reduction of its holdings in Markforged. On Monday, ARK sold 414 shares across its ARKQ and ARKX (NYSE:ARKX) ETFs, while on Tuesday of the previous week, it sold 545 shares. This gradual sell-off indicates a consistent trimming of ARK's investment in the 3D printing company.

The past trade data also highlights ARK's divestment from Senti Biosciences Inc (NASDAQ:SNTI) and Butterfly Network Inc (NYSE:BFLY), with substantial sales recorded on Friday, December 6th. In contrast, ARK has been accumulating shares of Tempus AI Inc (NASDAQ:TEM) and Absci Corp (NASDAQ:ABSI), as evidenced by significant purchases throughout the past week.

The most substantial trade from the previous week was ARK's purchase of 84,045 shares of Tempus AI, a company specializing in artificial intelligence for healthcare, through its ARKK and ARKG ETFs, amounting to a notable investment of over $4.2 million. This investment demonstrates ARK's bullish stance on the potential of AI in revolutionizing the healthcare industry.

In summary, while Tuesday's trading activity was relatively quiet with a single trade, the pattern of ARK's transactions over the past week paints a clear picture of the firm's strategic shifts. Investors following Cathie Wood's ARK ETFs should note the continued interest in AI healthcare technologies and the gradual distancing from certain holdings, which could signal a recalibration of ARK's innovative investment approach.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.